Skip to main content

Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults.

Publication ,  Journal Article
Mocroft, A; Neuhaus, J; Peters, L; Ryom, L; Bickel, M; Grint, D; Koirala, J; Szymczak, A; Lundgren, J; Ross, MJ; Wyatt, CM ...
Published in: PLoS One
2012

UNLABELLED: Chronic kidney disease (CKD) is an important cause of morbidity and mortality in HIV-positive individuals. Hepatitis C (HCV) co-infection has been associated with increased risk of CKD, but prior studies lack information on potential mechanisms. We evaluated the association between HCV or hepatitis B (HBV) co-infection and progressive CKD among 3,441 antiretroviral-treated clinical trial participants. Progressive CKD was defined as the composite of end-stage renal disease, renal death, or significant glomerular filtration rate (eGFR) decline (25% decline to eGFR <60 mL/min/1.73 m(2) or 25% decline with a baseline <60). Generalized Estimating Equations were used to model the odds of progressive CKD. At baseline, 13.8% and 3.3% of participants were co-infected with HCV and HBV, respectively. Median eGFR was 111, and 3.7% developed progressive CKD. After adjustment, the odds of progressive CKD were increased in participants with HCV (OR 1.72, 95% CI 1.07-2.76) or HBV (OR 2.26, 95% CI 1.15-4.44). Participants with undetectable or low HCV-RNA had similar odds of progressive CKD as HCV seronegative participants, while participants with HCV-RNA >800,000 IU/ml had increased odds (OR 3.07; 95% CI 1.60-5.90). Interleukin-6, hyaluronic acid, and the FIB-4 hepatic fibrosis index were higher among participants who developed progressive CKD, but were no longer associated with progressive CKD after adjustment. Future studies should validate the relationship between HCV viremia and CKD. TRIAL REGISTRATION: ClinicalTrials.gov NCT00027352; NCT00004978.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

PLoS One

DOI

EISSN

1932-6203

Publication Date

2012

Volume

7

Issue

7

Start / End Page

e40245

Location

United States

Related Subject Headings

  • Young Adult
  • Viremia
  • Renal Insufficiency, Chronic
  • Prognosis
  • Middle Aged
  • Male
  • Liver Cirrhosis
  • Humans
  • Hepatitis C
  • Hepatitis B
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mocroft, A., Neuhaus, J., Peters, L., Ryom, L., Bickel, M., Grint, D., … ESPRIT  Study Group. (2012). Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults. PLoS One, 7(7), e40245. https://doi.org/10.1371/journal.pone.0040245
Mocroft, Amanda, Jacqueline Neuhaus, Lars Peters, Lene Ryom, Markus Bickel, Daniel Grint, Janak Koirala, et al. “Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults.PLoS One 7, no. 7 (2012): e40245. https://doi.org/10.1371/journal.pone.0040245.
Mocroft A, Neuhaus J, Peters L, Ryom L, Bickel M, Grint D, et al. Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults. PLoS One. 2012;7(7):e40245.
Mocroft, Amanda, et al. “Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults.PLoS One, vol. 7, no. 7, 2012, p. e40245. Pubmed, doi:10.1371/journal.pone.0040245.
Mocroft A, Neuhaus J, Peters L, Ryom L, Bickel M, Grint D, Koirala J, Szymczak A, Lundgren J, Ross MJ, Wyatt CM, INSIGHT SMART Study Group, ESPRIT  Study Group. Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults. PLoS One. 2012;7(7):e40245.

Published In

PLoS One

DOI

EISSN

1932-6203

Publication Date

2012

Volume

7

Issue

7

Start / End Page

e40245

Location

United States

Related Subject Headings

  • Young Adult
  • Viremia
  • Renal Insufficiency, Chronic
  • Prognosis
  • Middle Aged
  • Male
  • Liver Cirrhosis
  • Humans
  • Hepatitis C
  • Hepatitis B